Opko Capital Stock vs Current Deferred Revenue Analysis
OPK Stock | USD 1.32 0.02 1.54% |
Opko Health financial indicator trend analysis is much more than just breaking down Opko Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Opko Health is a good investment. Please check the relationship between Opko Health Capital Stock and its Current Deferred Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
Capital Stock vs Current Deferred Revenue
Capital Stock vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Opko Health Capital Stock account and Current Deferred Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Opko Health's Capital Stock and Current Deferred Revenue is -0.45. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Opko Health, assuming nothing else is changed. The correlation between historical values of Opko Health's Capital Stock and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Opko Health are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Capital Stock i.e., Opko Health's Capital Stock and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | -0.45 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Opko Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Opko Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.At this time, Opko Health's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 1.5 B this year, although the value of Discontinued Operations will most likely fall to about 93.2 K.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 596M | 534.4M | 390.2M | 199.8M | Cost Of Revenue | 1.2B | 716M | 631.4M | 663.0M |
Opko Health fundamental ratios Correlations
Click cells to compare fundamentals
Opko Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Opko Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.3B | 2.5B | 2.4B | 2.2B | 2.0B | 2.1B | |
Other Current Liab | 143.0M | 222.7M | 190.9M | 143.4M | 85.9M | 65.4M | |
Total Current Liabilities | 249.1M | 375.5M | 301.8M | 213.5M | 200.1M | 103.9M | |
Total Stockholder Equity | 1.6B | 1.7B | 1.7B | 1.6B | 1.4B | 1.5B | |
Property Plant And Equipment Net | 166.5M | 178.3M | 124.0M | 121.6M | 143.5M | 150.7M | |
Net Debt | 125.7M | 149.8M | 53.2M | 60.3M | 230.7M | 242.2M | |
Retained Earnings | (1.5B) | (1.5B) | (1.5B) | (1.8B) | (2.0B) | (1.9B) | |
Accounts Payable | 62.5M | 100.9M | 82.0M | 67M | 69.7M | 73.2M | |
Cash | 85.5M | 72.2M | 134.7M | 153.2M | 95.9M | 63.6M | |
Non Current Assets Total | 2.0B | 1.9B | 1.6B | 1.8B | 1.7B | 1.8B | |
Non Currrent Assets Other | 723.2M | 679.1M | 465.9M | 832.2M | (185.9M) | (176.6M) | |
Cash And Short Term Investments | 85.5M | 72.2M | 134.7M | 153.2M | 95.9M | 64.0M | |
Common Stock Shares Outstanding | 595.5M | 640.7M | 648.1M | 719.1M | 751.8M | 789.4M | |
Liabilities And Stockholders Equity | 2.3B | 2.5B | 2.4B | 2.2B | 2.0B | 2.1B | |
Other Stockholder Equity | 3.1B | 3.2B | 3.2B | 3.4B | 3.4B | 3.6B | |
Total Liab | 694.5M | 801.5M | 714.6M | 605.7M | 622.5M | 653.6M | |
Property Plant And Equipment Gross | 166.5M | 178.3M | 257.3M | 264.0M | 300.6M | 315.7M | |
Total Current Assets | 324M | 523.2M | 823M | 394.5M | 309.5M | 183.8M | |
Accumulated Other Comprehensive Income | (22.1M) | (4.2M) | (30.5M) | (43.3M) | (38.0M) | (36.1M) | |
Intangible Assets | 1.3B | 1.3B | 1.1B | 790.9M | 935.3M | 572.8M | |
Non Current Liabilities Total | 445.4M | 426M | 412.8M | 392.2M | 422.4M | 222.3M | |
Short Long Term Debt Total | 211.2M | 222M | 187.9M | 213.5M | 326.6M | 342.9M | |
Other Current Assets | 238.5M | 451M | 373.3M | 241.3M | 17.7M | 16.8M | |
Short Term Debt | 24.4M | 36.2M | 28.6M | 3.1M | 43.1M | 45.3M | |
Common Stock Total Equity | 5.9M | 6.7M | 6.7M | 6.9M | 7.9M | 8.3M | |
Common Stock | 6.7M | 6.7M | 6.9M | 7.8M | 7.8M | 8.2M | |
Other Liab | 153.8M | 204M | 196.7M | 126.4M | 145.4M | 142.0M | |
Other Assets | 7.0M | 653.7M | 465.9M | 981.9M | 1.1B | 1.2B | |
Property Plant Equipment | 144.7M | 166.5M | 178.3M | 124.0M | 142.5M | 149.7M | |
Current Deferred Revenue | 19.2M | 15.8M | 258K | 1.4M | 1.6M | 1.5M | |
Long Term Debt | 259.9M | 225.8M | 187.9M | 219.5M | 222.0M | 121.6M | |
Net Receivables | 157.7M | 302.3M | 265.6M | 148.6M | 130.2M | 117.8M | |
Inventory | 53.4M | 132.3M | 86.5M | 74.1M | 65.7M | 42.4M | |
Good Will | 671.9M | 680.6M | 520.6M | 595.9M | 598.3M | 421.7M | |
Net Tangible Assets | 413.9M | 515.9M | 574.3M | 770.7M | 886.3M | 930.6M | |
Retained Earnings Total Equity | (1.2B) | (1.5B) | (1.5B) | (1.5B) | (1.4B) | (1.4B) | |
Capital Surpluse | 3.0B | 3.1B | 3.2B | 3.2B | 3.7B | 2.5B |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Opko Health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Opko Stock analysis
When running Opko Health's price analysis, check to measure Opko Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opko Health is operating at the current time. Most of Opko Health's value examination focuses on studying past and present price action to predict the probability of Opko Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opko Health's price. Additionally, you may evaluate how the addition of Opko Health to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is Opko Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.35) | Revenue Per Share 1.08 | Quarterly Revenue Growth (0.27) | Return On Assets (0.06) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.